Introduction
============

*Chromobacterium violaceum* is a gram negative, rod shaped, nonsporing, and motile bacteria that can utilize carbohydrate fermentatively and grows readily on the ordinary laboratory culture media at 35°C--37°C.[@b1-ijgm-9-441] It naturally resides in soil and stagnant water of tropical and subtropical regions as saprophyte[@b2-ijgm-9-441] and produces a chemical antioxidant compound called violacein (violet non-diffusible pigment).[@b3-ijgm-9-441] Although first identified in 1881, its pathogenic potential was illustrated only in 1905 by Woolley from a fatal case of a buffalo in Philippines.[@b4-ijgm-9-441] Human case of infection caused by this pathogen was first established by Lessler from Malaysia in 1927.[@b4-ijgm-9-441] This organism is usually considered as nonpathogenic, but it is an opportunistic pathogen of extreme virulence for humans and animals when inoculated into bloodstream via open wound.[@b5-ijgm-9-441] Several reports of serious and fatal infections have been reported worldwide, especially from Asian and American countries. In majority of these cases, bacteria entered through the breached or abraded skins subsequently after exposure to contaminated soil or water.[@b6-ijgm-9-441] Clinical disease caused by this organism ranges from a localized skin lesion to multiple abscesses in the vital organs and fatal septicemia.[@b7-ijgm-9-441],[@b8-ijgm-9-441] Here we report a new case of bacteremia caused by *C. violaceum* at Manmohan Memorial Medical College Teaching Hospital (MMTH), Kathmandu, Nepal. To the best of our knowledge, this is the first case of culture-proven bacteremia caused by *C. violaceum* from Nepal.

Written informed consent was taken from the patient for necessary investigations and case publication in scientific journal.

Case report
===========

A 36-year-old immunocompetent female presented at midnight of 24 August 2016 to the emergency department of MMTH, a tertiary care referral hospital in Kathmandu, the capital of Nepal, with the clinical symptoms of fever, headache, chills, excessive sweating, burning sensation over epigastric region, and shortness of breath for the past 12 hours. There was no nausea, no vomiting, and normal bowel. She denied any previous illness, but her husband recalled that she had previously been diagnosed with pulmonary tuberculosis and treated with isoniazid and ethambutol as a directly observed therapy 6 years back. She lived in Sitapaila, a nearby village, and spent her life as an active housewife until 3 days ago when she plucked her left toe while working in the paddy farmland. Thereafter, her left toe became inflamed and swollen with edematous ulceration.

On examination, the patient was conscious and alert, but ill-looking. Local examination showed indurations above the toe region that was edematous, but not discharging pus or any serous fluid. Furthermore, she had blood pressure of 110/70 mmHg, pulse rate of 110 beats per minute, temperature of 39.6°C, and respiratory rate of 22 breaths per minute. The patient was provisionally diagnosed as a case of acute febrile illness with a suspicion of wound-related sepsis and immediate management was started. After necessary physical examination, blood and urine samples were collected aseptically for laboratory investigations viz blood culture, urine culture, hematology parameters, widal test, and blood chemistry tests. Paracetamol (500 mg) and Ibuprofen (400 mg) were administered by parenteral route along with electrolyte fluids. After specimen collection for laboratory investigations, the patient was admitted to the medical unit for further treatment. Antimicrobial regimen of 400 mg/24-hour of ciprofloxacin and 2 g/24-hour of ceftriaxone were initiated as empiric therapy for gram negative sepsis immediately after admission.

Hematological findings
======================

The hematological investigations showed a normal (unremarkable) level of total leukocyte count with adequate cellular distribution, but low hemoglobin concentration ([Table 1](#t1-ijgm-9-441){ref-type="table"}). Other blood cell parameters and indices were found in the acceptable range.

Blood chemistry findings
------------------------

The clinical parameters of blood glucose, urea, electrolytes, and common liver enzymes were found normal ([Table 2](#t2-ijgm-9-441){ref-type="table"}). Widal test titer, serological test for enteric fever, was also insignificant in validating that there was no such infectious cause in the disease. C-reactive protein by latex agglutination was also negative. Urine microscopy and chemical findings were normal. Abdominal ultrasonography was also unremarkable.

Microbiological findings
------------------------

Blood and urine samples were subjected for bacteriological cultivation. Ten milliliters of blood sample was aseptically inoculated into brain heart infusion broth and incubated in aerobic atmosphere for 24 hours. Urine sample was inoculated into blood agar and MacConkey agar plates semi-quantitatively and incubated aerobically for 24 hours at 37°C. Blood culture broth was inspected next day, and blind subculture was made on blood agar, chocolate agar, and MacConkey agar and incubated for next 24 hours. Urine culture plates were found with no growth of any bacterial species and reported as sterile.

After overnight incubation of subcultured plates from blood culture, the agar plates demonstrated numerous small colonies with a faint violet metallic pigmentation (which later became dark violet on incubation) with no hemolysis ([Figure 1](#f1-ijgm-9-441){ref-type="fig"}). For better demonstration of pigment, we transferred the colonies to fresh nutrient agar plate ([Figure 2](#f2-ijgm-9-441){ref-type="fig"}) and incubated aerobically for next 24 hours. Some colonies on the nutrient agar were initially nonpigmented, but later converted to dark violet on prolonged incubation (72 hours) at room temperature.

Biochemical characterization of the bacteria was carried out by conventional biochemical tests such as catalase test, oxidase test, triple sugar iron agar test, citrate utilization, urea hydrolysis, sulfide indole motility, oxidation--fermentation test, methyl red-Voges--Proskauer test, decarboxylase tests (lysine, arginine, and ornithine). The oxidase test was performed by picking the single isolated colony with the sterile bamboo stick and rubbing over the surface of the filter paper disk impregnated with 1% tetra methyl paraphenylene diamine dihydrochloride reagent. Citrate utilization test was done by using Simmons citrate agar. All the results of biochemical tests are summarized in [Figure 3](#f3-ijgm-9-441){ref-type="fig"} and [Table 3](#t3-ijgm-9-441){ref-type="table"}. Simultaneously, antimicrobial susceptibility test was performed by Kirby-Bauer disk diffusion method on Mueller-Hinton agar using commercially available antibiotic disks ([Figures 4](#f4-ijgm-9-441){ref-type="fig"}; [5](#f5-ijgm-9-441){ref-type="fig"}) and the result of the susceptibility test was interpreted according to the Clinical and Laboratory Standards Institute guidelines for non-fermenting gram negatives.[@b9-ijgm-9-441]

The patient was responding better after initial antimicrobial therapy, and fever subsidized after 8 hours. Empirical antibiotic therapy was continued until the complete laboratory reports were available. Based on the biochemical findings and microscopic observation (Gram staining, motility), the organism was confirmed as *C. violaceum.* Antimicrobial susceptibility test indicated that it is resistant to polymixin group of antibiotics, but susceptible to other therapeutic antibiotics ([Table 4](#t4-ijgm-9-441){ref-type="table"}).

The initial antimicrobial regime was found susceptible and continued for 14 days. Additional blood culture was performed on day 6 to confirm the prognosis, but was negative for bacterial growth. She was discharged on day 7 on oral ciprofloxacin (1,000 mg/24 hours) and cefixime (500 mg/24 hours) for next 9 days (total 14 days). On followup visit, the wound appeared dry, crusty, and membranous without any serous fluid. After completion of the therapy, she made absolute recovery without any complications and the antibiotics were discontinued.

Discussion
==========

*C. violaceum* is the single species of the genus responsible for human infections.[@b10-ijgm-9-441] Most clinicians are unaware of this rare bacterium despite its ubiquitous distribution.[@b6-ijgm-9-441] In the published literature, common clinical features in majority of the cases with fatal outcome appear to be sepsis, multiple liver abscesses, and diffuse pustular dermatitis.[@b4-ijgm-9-441] Bacteremia associated with *C. violaceum* has been reported by Chen et al and Yang et al from Taiwan,[@b7-ijgm-9-441],[@b11-ijgm-9-441] Campbell et al from Vietnam,[@b5-ijgm-9-441] Ray et al from India,[@b4-ijgm-9-441] Nanayakkara et al from Sri Lanka,[@b12-ijgm-9-441] and others. Most of the reported cases had the fatal outcome but successful therapeutic experience with the use of timely therapy has also been reported.[@b5-ijgm-9-441]

Although *C. violaceum* is confined to tropical countries, especially in South and Southeast Asia, there are only two previously reported cases from Nepal. Of the two cases, the wound sepsis case by Ansari et al has demonstrated the fatality of the case while another asymptomatic bacteriuria by Pant et al was self-limiting.[@b13-ijgm-9-441],[@b14-ijgm-9-441] Blood culture confirmed bacteremia associated with this rare pathogen has not been reported from Nepal yet. In this case, clinical features of the febrile woman appear to be similar to that of common enteric fever, but skin lesion and isolated bacterial strain helped in timely identification of the rare case of bacteremia. Besides, previous studies suggested that the common predisposing factors for *C. violaceum* associated bacteremia were immunocompromised state, chronic granulomatous disease, steroid therapy, diabetes, and other systemic illnesses,[@b6-ijgm-9-441],[@b10-ijgm-9-441] but in this report there were no such factors to be noted.

Consumption of contaminated water or food or through exposure of damaged skin to stagnant water or soil is a common route for transmission of this pathogen to healthy individuals. Moreover, severe infections after swimming in contaminated water, recreational or stagnant muddy water, and post-surgical cases have also been reported.[@b6-ijgm-9-441] In this case, too, there was sufficient evidence of inoculation of the pathogen and symptoms were also promising although undifferentiated. The ability of the organism to produce a peculiar metabolite violacein giving the colonies their distinctive purple color helped in proper identification of the bacteria. Nevertheless, nonpigmented strains of *C. violaceum* have also been involved in human infections.[@b11-ijgm-9-441],[@b15-ijgm-9-441]

*Chromobacterium* is usually susceptible to therapeutic antimicrobials, however genes associated with intrinsic resistance toward penicillins and early cephalosporins have been described.[@b16-ijgm-9-441] Isolates have been found susceptible to common therapeutic antimicrobials like chloramphenicol, trimethoprim sulfamethoxazole, tetracyclines, ciprofloxacin, cefepime, and imipenem.[@b17-ijgm-9-441] Therefore, broad-spectrum cephalosporins, carbapenems or fluoroquinolones can be used as an appropriate initial choice for *C. violaceum* infections due to the unavailability of recommended therapeutic guidelines. Timely diagnosis and aggressive antimicrobial therapy would be a critical factor for an effective management of *C. violaceum* and reduce the high mortality associated with these infections.[@b5-ijgm-9-441],[@b7-ijgm-9-441] In our case, timely intervention with administration of broad-spectrum antibiotics to which the organism was sensitive, assisted in proper management of the illness, and the infection did not progress to septicemia and other complications.

Conclusion
==========

Although human infections with *C. violaceum* are rare, they are often associated with higher morbidity and mortality. Nevertheless, the clinical symptoms and presentation of the infection are not distinctive, it should be included in differential diagnosis of sepsis, especially if exposure to stagnant water and skin breaching is involved. Early clinical detection and administration of the appropriate systemic antimicrobial therapy is highly recommended.
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###### 

Hematological findings of the case on admission

  Tests (reference range)                         Results/findings
  ----------------------------------------------- -------------------
  Hemoglobin (12--16 g/dL)                        10.2 g/dL
  Total leucocytes (4,000--10,000 cells/mm^3^)    7,100/mm^3^
  Differential leucocytes count                   
   Polymorphs (40%--70%)                          70%
   Lymphocytes (20%--45%)                         25%
   Eosinophils (1%--6%)                           03%
   Monocytes (2%--10%)                            02%
   Basophils (0%--2%)                             00%
  PCV (37%--48%)                                  37%
  Total red cell count (4.2--5.4 million/mm^3^)   4.2 million/mm^3^
  MCV (80--100 fL)                                82 fL
  MCH (27--32 pg)                                 29.9 pg
  MCHC (32%--36%)                                 35.1%
  Total platelet count (1.5--4.5 lakhs/mm^3^)     275,000/mm^3^

**Abbreviations:** MCV, mean corpuscular volume; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration; PCV, packed cell volume.

###### 

Blood chemistry results of case on admission

  Tests (reference range)             Results/findings
  ----------------------------------- ------------------
  Glucose, random (70--140 mg/dL)     118 mg/dL
  Blood urea (15--45 mg/dL)           27 mg/dL
  Serum creatinine (0.6--1.1 mg/dL)   0.7 mg/dL
  Sodium (135--146 mEq/L)             143 mEq/L
  Potassium (3.5--5.2 mEq/L)          3.9 mEq/L
  SGOT (AST) (\<40 IU/L)              33 IU/L
  SGPT (ALT) (\<37 IU/L)              30 IU/L
  ALP (90--460 IU/L)                  144 IU/L
  Serum amylase (25--115 IU/L)        66 IU/L

**Abbreviations:** ALT, alanine aminotransferase; ALP, alkaline phosphatase; AST, aspartate aminotransferase; SGOT, serum glutamic oxaloacetic transaminase; SGPT, serum glutamate pyruvate transaminase.

###### 

Biochemical findings of the bacterial isolate from case

  Biochemical tests performed            Results
  -------------------------------------- -----------------------
  Gram stain                             Gram negative bacilli
  Catalase test                          Positive
  Oxidase test                           Positive
  TSI agar                               
   Acid production in slant              Negative
   Acid production in butt               Positive
   Hydrogen sulfide production           Negative
   Gas production                        Negative
   Glucose fermentation                  Positive
   Lactose and/or sucrose fermentation   Negative
   Alkali production in slant            Positive
  SIM                                    
   Motility                              Positive
   Hydrogen sulfide production           Negative
   Indole                                Negative
  Urea hydrolysis test                   Negative
  Citrate utilization test               Positive
  Methyl red test                        Negative
  Voges--Proskauer test                  Negative
  OF test                                Fermentative
  Decarboxylase tests                    
   Lysine decarboxylase                  Negative
   Arginine dihydrolase                  Positive
   Ornithine decarboxylase               Negative
  DNAse test                             Positive
  Pigment                                Violet (violacein)

**Abbreviations:** DNAse, deoxyribonuclease; OF, oxidation--fermentation; SIM, sulfide indole motility; TSI, triple sugar iron.

###### 

Antibiogram of *Chromobacterium violaceum* clinical isolate from the case

  Antibiotics               Results
  ------------------------- -----------
  Ampicillin                Resistant
  Cotrimoxazole             Sensitive
  Ceftazidime               Sensitive
  Cefixime                  Sensitive
  Ciprofloxacin             Sensitive
  Levofloxacin              Sensitive
  Gentamycin                Sensitive
  Amikacin                  Sensitive
  Piperacillin tazobactam   Sensitive
  Ampicillin sulbactam      Resistant
  Cefoperazone sulbactam    Sensitive
  Imipenem                  Sensitive
  Meropenem                 Sensitive
  Polymixin B               Resistant
  Colistin sulfate          Resistant
